Literature DB >> 8594931

Lesions of area postrema attenuate but do not prevent anorectic action of peripheral serotonin in rats.

V Adipudi1, K J Simansky.   

Abstract

These studies assessed the effect of selectively ablating the area postrema (AP) on the action of peripheral serotonin [5-hydroxytryptamine (5-HT)] to reduce food intake in rats. Intraperitoneal 5-HT (0, 2.0, 4.0, and 8.0 mumol/kg) reduced the intakes of sweetened mash during a 30-min test in controls (APC) and in AP-lesioned rats (APX). The anorexia was dose dependent in controls but the dose-response function was flat after AP lesions. In another study, 2.0 mumol/kg 5-HT reduced intakes of both groups by approximately 25%, but AP lesions blunted the effect at 8.0 mumol/kg 5-HT (APX, -30% vs. APC, -85%). Behavioral analysis revealed that, compared with controls, AP lesions eliminated the decrease in frequency of feeding and reduced the incidence of resting and of an aberrant posture observed after 8.0 mumol/kg. Thus peripheral 5-HT decreases food intake in rats with AP lesions. Multiple mechanisms appear to be involved in the ability of peripheral 5-HT to reduce feeding. A high dose of 5-HT promotes responses associated with satiation but also produces behavioral toxicity; these effects involve the AP. Lower doses appear to engage processes that do not rely on the function of this circumventricular organ.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8594931     DOI: 10.1152/ajpregu.1995.269.6.R1314

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  A diffusion barrier between the area postrema and nucleus tractus solitarius.

Authors:  Qing-Ping Wang; Jian-Lian Guan; Weihong Pan; Abba J Kastin; Seiji Shioda
Journal:  Neurochem Res       Date:  2008-03-29       Impact factor: 3.996

2.  Gastrointestinal Distension by Pectin-Containing Carbonated Solution Suppresses Food Intake and Enhances Glucose Tolerance via GLP-1 Secretion and Vagal Afferent Activation.

Authors:  Kento Ohbayashi; Yukiko Oyama; Chiharu Yamaguchi; Toshiki Asano; Toshihiko Yada; Yusaku Iwasaki
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-08       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.